MAP2K7 and acute lymphoblastic leukemia: These observations provide new insights into the biological bases of clinically observed GCs resistance and demonstrate that modulation of autophagy by MEK/ERK pathway is a new, targetable mechanism of GC resistance in B-ALL patients.